NZ King Salmon Battles $20.8M Loss Amid Biological Setbacks and Growth Push

• 1HY25 net loss of $20.8 million due to $22.5 million biological asset write-down
• Pro-forma EBITDA declined to $5.7 million from $13.5 million year-on-year
• Sales volumes dropped 17%, revenues down 7% compared to prior period
• Board maintains FY25 EBITDA guidance of $1m–$7m, targeting upper half